Encouraging results with the compassionate use of hydralazine/valproate (TRANSKRIP™) as epigenetic treatment for myelodysplastic syndrome (MDS).
about
Encouraging results with the compassionate use of hydralazine/valproate (TRANSKRIP™) as epigenetic treatment for myelodysplastic syndrome (MDS).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Encouraging results with the c ...... yelodysplastic syndrome (MDS).
@en
Encouraging results with the compassionate use of hydralazine/valproate
@nl
type
label
Encouraging results with the c ...... yelodysplastic syndrome (MDS).
@en
Encouraging results with the compassionate use of hydralazine/valproate
@nl
prefLabel
Encouraging results with the c ...... yelodysplastic syndrome (MDS).
@en
Encouraging results with the compassionate use of hydralazine/valproate
@nl
P2093
P2860
P1433
P1476
Encouraging results with the c ...... myelodysplastic syndrome (MDS)
@en
P2093
Alfonso Dueñas-Gonzalez
Mayra Ponce
Ramiro Espinoza
Sebastian Burgos
P2860
P304
P356
10.1007/S00277-017-3103-X
P577
2017-08-23T00:00:00Z